Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

727 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of Complete Revascularization on Development of Heart Failure in Patients With Acute Coronary Syndrome and Multivessel Disease: A Subanalysis of the CORALYS Registry.
Bruno F, Marengo G, De Filippo O, Wanha W, Leonardi S, Raposeiras Roubin S, Fabris E, Popovic M, Giannino G, Truffa A, Huczek Z, Gaibazzi N, Ielasi A, Cortese B, Borin A, Núñez-Gil IJ, Melis D, Ugo F, Bianco M, Barbieri L, Marchini F, Desperak P, Montalto C, Melendo-Viu M, Elia E, Mancone M, Buono A, Ferrandez-Escarabajal M, Morici N, Scaglione M, Tuttolomondo D, Sardella G, Gasior M, Mazurek M, Gallone G, Campo G, Wojakowski W, Abu-Assi E, Sinagra G, De Ferrari GM, D'Ascenzo F; Collaborators. Bruno F, et al. Among authors: campo g. J Am Heart Assoc. 2023 Aug;12(15):e028475. doi: 10.1161/JAHA.122.028475. Epub 2023 Jul 25. J Am Heart Assoc. 2023. PMID: 37489724 Free PMC article. Clinical Trial.
Sex-specific benefits of sirolimus-eluting stent on long-term outcomes in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: insights from the Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study trial.
Ferrante G, Presbitero P, Corrada E, Campo G, Bolognese L, Vassanelli C, Colangelo S, De Cesare N, E Rodriguez A, Bramucci E, Moreno R, Piva T, Sheiban I, Pasquetto G, Prati F, Nazzaro MS, Ferrari R, Valgimigli M. Ferrante G, et al. Among authors: campo g. Am Heart J. 2012 Jan;163(1):104-11. doi: 10.1016/j.ahj.2011.09.026. Am Heart J. 2012. PMID: 22172443 Clinical Trial.
Bioresorbable Scaffold vs. Second Generation Drug Eluting Stent in Long Coronary Lesions requiring Overlap: A Propensity-Matched Comparison (the UNDERDOGS study).
Biscaglia S, Ugo F, Ielasi A, Secco GG, Durante A, D'Ascenzo F, Cerrato E, Balghith M, Pasquetto G, Penzo C, Fineschi M, Bonechi F, Templin C, Menozzi M, Aquilina M, Rognoni A, Capasso P, Di Mario C, Brugaletta S, Campo G. Biscaglia S, et al. Among authors: campo g. Int J Cardiol. 2016 Apr 1;208:40-5. doi: 10.1016/j.ijcard.2016.01.202. Epub 2016 Jan 21. Int J Cardiol. 2016. PMID: 26826788
Impact of proton pump inhibitors on clinical outcomes in patients treated with a 6- or 24-month dual-antiplatelet therapy duration: Insights from the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY trial.
Gargiulo G, Costa F, Ariotti S, Biscaglia S, Campo G, Esposito G, Leonardi S, Vranckx P, Windecker S, Valgimigli M. Gargiulo G, et al. Among authors: campo g. Am Heart J. 2016 Apr;174:95-102. doi: 10.1016/j.ahj.2016.01.015. Epub 2016 Jan 25. Am Heart J. 2016. PMID: 26995375 Clinical Trial.
Meta-Analysis of the Duration of Dual Antiplatelet Therapy in Patients Treated With Second-Generation Drug-Eluting Stents.
D'Ascenzo F, Moretti C, Bianco M, Bernardi A, Taha S, Cerrato E, Omedè P, Montefusco A, Frangieh AH, Lee CW, Campo G, Chieffo A, Quadri G, Pavani M, Zoccai GB, Gaita F, Park SJ, Colombo A, Templin C, Lüscher TF, Stone GW. D'Ascenzo F, et al. Among authors: campo g. Am J Cardiol. 2016 Jun 1;117(11):1714-23. doi: 10.1016/j.amjcard.2016.03.005. Epub 2016 Mar 19. Am J Cardiol. 2016. PMID: 27134057 Review.
A prospective evaluation of a standardized strategy for the use of a polymeric everolimus-eluting bioresorbable scaffold in ST-segment elevation myocardial infarction: Rationale and design of the BVS STEMI STRATEGY-IT study.
Ielasi A, Varricchio A, Campo G, Leoncini M, Cortese B, Vicinelli P, Brugaletta S, di Uccio FS, Latib A, Tespili M. Ielasi A, et al. Among authors: campo g. Catheter Cardiovasc Interv. 2017 Jun 1;89(7):1129-1138. doi: 10.1002/ccd.26801. Epub 2016 Oct 24. Catheter Cardiovasc Interv. 2017. PMID: 27774758
Radial versus femoral access in patients with acute coronary syndromes with or without ST-segment elevation.
Vranckx P, Frigoli E, Rothenbühler M, Tomassini F, Garducci S, Andò G, Picchi A, Sganzerla P, Paggi A, Ugo F, Ausiello A, Sardella G, Franco N, Nazzaro M, de Cesare N, Tosi P, Falcone C, Vigna C, Mazzarotto P, Di Lorenzo E, Moretti C, Campo G, Penzo C, Pasquetto G, Heg D, Jüni P, Windecker S, Valgimigli M; MATRIX Investigators. Vranckx P, et al. Among authors: campo g. Eur Heart J. 2017 Apr 7;38(14):1069-1080. doi: 10.1093/eurheartj/ehx048. Eur Heart J. 2017. PMID: 28329389 Free article. Clinical Trial.
727 results